WebDenovo Biopharma LLC Announces FDA Approval of IND to Initiate First Biomarker-Guided Global CNS Clinical Trial for Treatment-Resistant Depression (TRD) BioSpace. WebJul 6, 2024 · Denovo Biopharma LLC is a clinical-stage biopharmaceutical company that uses novel biomarker approaches to executes efficient clinical trials in targeted patient populations to optimize the ...

Denovo Biopharma - Overview, News & Competitors

WebSep 17, 2014 · Denovo Biopharma is a privately-held biotechnology company that provides novel and proprietary biomarker approaches to personalized drug development, … WebJan 3, 2024 · Denovo Biopharma is a privately-held clinical stage biotechnology company that provides novel and proprietary biomarker approaches to advance drug development, including re-evaluating medicines that have failed in general patient populations by stratifying the responders for the original indication. ein for individual

Denovo Biopharma LinkedIn

WebDenovo Biopharma has raised a total of CN¥1.2B in funding over 4 rounds. Their latest funding was raised on Dec 10, 2024 from a Series D round. Denovo Biopharma is funded by 14 investors. CICC Qide and Zhejiang Silicon Paradise Asset Management Group are the most recent investors. Funding Rounds Number of Funding Rounds 4 WebDenovo Biopharma, LLC operates as a bio-technology company. The Company provides a novel biomaker solution to personalize drug development. Denovo Biopharma serves … WebJan 31, 2024 · Denovo Biopharma LLC ("Denovo"), a pioneer in applying precision medicine to the development of innovative therapies, today announced that the FDA has … ein for individual 401k